IL6 and pancreatic neoplasm: Overexpression of the MSLN gene was shown to enhance interleukin (IL)-6 signaling [11], and to confer resistance to tumor necrosis factor (TNF)-α mediated apoptosis in pancreatic cancer cell lines [20].